AI Predictions From The CPHI Annual Report
Source: Life Science Leader
By Dan Schell, Chief Editor, Clinical Leader
The CPHI Annual Report 2023 that was released last month includes insights from 250 global pharma companies and predicts that “Within 10 years, over 50% of approved drugs will involve AI in their development and/or manufacturing.” CPHI Report expert Bikash Chatterjee, who is CSO at Pharmatech Associates, a USP Company, comments below on some of the report’s AI findings:
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more